These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 16944471)
1. The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs. Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T J Orthop Res; 2006 Nov; 24(11):2133-40. PubMed ID: 16944471 [TBL] [Abstract][Full Text] [Related]
2. Prolonged survival of experimental extremity allografts: a new protocol with total body irradiation, granulocyte-colony stimulation factor, and FK506. Muramatsu K; Kuriyama R; Kato H; Yoshida Y; Taguchi T J Orthop Res; 2010 Apr; 28(4):457-61. PubMed ID: 19877287 [TBL] [Abstract][Full Text] [Related]
3. Prolonged survival of rat whole-limb allografts treated with cyclophosphamide, granulocyte colony-stimulation factor and FK506. Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Gondo T; Taguchi T Transpl Int; 2006 Oct; 19(10):840-7. PubMed ID: 16961777 [TBL] [Abstract][Full Text] [Related]
4. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts. Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288 [TBL] [Abstract][Full Text] [Related]
5. Chimerism studies as an approach for the induction of tolerance to extremity allografts. Muramatsu K; Kuriyama R; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1009-15. PubMed ID: 18573704 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers. Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943 [TBL] [Abstract][Full Text] [Related]
7. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257 [TBL] [Abstract][Full Text] [Related]
9. Donor cell engraftment in recipient lymphoid tissues after rat limb allograft. Muramatsu K; Kurokawa Y; Ihara K; You-Xin S; Kawai S J Surg Res; 2005 Mar; 124(1):38-44. PubMed ID: 15734477 [TBL] [Abstract][Full Text] [Related]
11. Myeloablative irradiation and granulocyte colony-stimulating factor prolong the survival of chimeric limb allografts in a rodent model. Muramatsu K; Kato H; Yoshida Y; Moriya A; Taguchi T Plast Reconstr Surg; 2010 Jul; 126(1):53-60. PubMed ID: 20595856 [TBL] [Abstract][Full Text] [Related]
12. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246 [TBL] [Abstract][Full Text] [Related]
13. Detection of chimerism following vascularized bone allotransplantation by polymerase chain reaction using a Y-chromosome specific primer. Muramatsu K; Valenzuela RG; Bishop AT J Orthop Res; 2003 Nov; 21(6):1056-62. PubMed ID: 14554219 [TBL] [Abstract][Full Text] [Related]
15. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts. Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139 [TBL] [Abstract][Full Text] [Related]
16. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients. Askenasy N; Yolcu ES; Shirwan H; Wang Z; Farkas DL Stem Cells; 2003; 21(2):200-7. PubMed ID: 12634416 [TBL] [Abstract][Full Text] [Related]
17. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)]. Weigao C Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057 [TBL] [Abstract][Full Text] [Related]
18. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation. Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680 [TBL] [Abstract][Full Text] [Related]
19. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance. Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178 [TBL] [Abstract][Full Text] [Related]
20. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells. Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]